Page last updated: 2024-08-22

angiotensin ii and ramipril

angiotensin ii has been researched along with ramipril in 126 studies

Research

Studies (126)

TimeframeStudies, this research(%)All Research%
pre-199026 (20.63)18.7374
1990's45 (35.71)18.2507
2000's41 (32.54)29.6817
2010's10 (7.94)24.3611
2020's4 (3.17)2.80

Authors

AuthorsStudies
Brockmeier, D; Heintz, B; Kierdorf, H; Kirsten, R; Lückel, G; Maigatter, S; Nelson, K; Rangoonwala, B; Sieberth, HG; Verho, M1
Carretero, OA; Farhy, RD; Ho, KL; Scicli, AG1
Huysmans, FT; Koene, RA; Sluiter, HE; van Hamersvelt, HW; Wetzels, JF1
Jahnecke, C; Kappes-Horn, K; Kramer, HJ; Meyer-Lehnert, H1
Akbary, A; Chen-Gal, B; Erman, A; Levi, E; Rabinov, M; Rosenfeld, JB; Shmueli, J; Tadjer, S; Winkler, J; Zelykovski, A1
Benetos, A; Safar, M; Thiéry, P; Vasmant, D1
Blöchl, A; Dominiak, P2
Henning, R; Linz, W; Schölkens, BA1
Goodman, SA; Gould, AB1
Iimura, O; Nakagawa, M; Shimamoto, K1
Bönner, G; Danckwardt, L; Rettig, R; Shimizu, I; Unger, T1
Hayashi, S; Izumi, H1
Collier, JG; Webb, DJ2
Kimura, B; Phillips, MI1
Debusmann, ER; Grötsch, H; Irmisch, R; Jane, F; Lahn, W; Mora, J; Ocón-Pujadas, J1
Iimura, O; Shimamoto, K2
Ehmke, H; Kirchheim, H; Kögler, U; Persson, PB1
Ganten, D; Linz, W; Schölkens, BA1
Craig, K; MacDonald, TM; Watson, ML1
Albus, U; Just, M; Kaiser, J; Linz, W; Petry, P; Qi, BY; Schölkens, BA1
Brunner, HR; Nussberger, J; Waeber, B1
Abrahamsson, T; Carlsson, L1
Fregly, MJ; Rowland, NE1
Bührle, CP; Rosivall, L; Taugner, R1
Ganten, D; Jin, M; Lang, RE; Lindpaintner, K; Schoelkens, BA; Unger, T; Wilhelm, MJ1
Giesen-Crouse, E; Imbs, JL; Krieger, JP; Schmidt, M; Welsch, C1
Bayer, C; Ganten, D; Hermann, K; Lang, RE; Unger, T1
Brigden, GS; Caruana, MP; Heber, ME; Lahiri, A; Raftery, EB1
Vierhapper, H; Waldhäusl, W; Witte, PU1
Ball, SG; Leckie, BJ; Malatino, LS; Manhem, P; Morton, JJ; Murray, GD; Robertson, JI1
Ganten, D; Lang, RE; Moursi, MG; Unger, T1
Adams, FG; Gillen, G; Morton, JJ; Robertson, JI; Tillman, DM1
Han, YF; Linz, W; Schölkens, BA1
Kimura, BK; Phillips, MI1
Schacht, U1
Berkenboom, G; Brékine, D; Fontaine, J; Gulbis, B; Unger, P1
Traub, O; Watts, SW; Webb, RC1
Hartman, JC1
Hamann, M; Hegyi, I; Kaissling, B; Kurtz, A; Schricker, K1
Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH1
Amtorp, O; Gundersen, T; Nilsson, B; Remes, J; Sigurdsson, A; Swedberg, K1
Carlyle, PF; Cohn, JN; Francis, GS; Garr, M; Hauer, K; Hunter, DW; McDonald, KM; Parish, T; Stillman, A1
Sigurdsson, A; Swedberg, K; Ullman, B1
Hamann, M; Holmer, S; Kurtz, A; Riegger, G; Schricker, K1
Allan, DR; Coletti, CM; Hollenberg, NK; Kifor, I; McKnight, JA1
McDaniel, PA; Riddle, MC1
Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G1
Brasch, H; Dominiak, P; Sieroslawski, L1
Flood, JF; Morley, JE1
Chatterjee, K; Ives, HE; Sudhir, K; Wilson, E1
Finta, KM; Fischer, MJ; Gordon, D; Lee, L; Pitt, B; Webb, RC1
Campbell, DJ; Duncan, AM; Kladis, A1
Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM1
Lloyd, MC; Traub, O; Webb, RC1
Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS1
DiPette, DJ; Wang, DH; Yao, A; Zhao, H1
Bauer, JH; Campbell, F; Knaus, J; Reams, G; Weaver-Osterholtz, D; Wu, Z1
Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Oliveira, RC; Santos, RA1
Dunham, EW; Zhang, X; Zimmerman, BG1
Barthelmebs, M; Grima, M; Imbs, J; Stephan, D; Vasmant, D; Welsch, M1
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD1
Dam, JP; Porsius, AJ; Post, MJ; Riezebos, J; Vleeming, W; Wemer, J1
Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S1
Barthelmebs, M; Grima, M; Imbs, JL; Ingert, C; Michel, B1
Bech, JN; Hansen, HE; Jensen, KT; Kornerup, HJ; Nielsen, CB; Pedersen, EB; Spencer, ES; Sølling, J1
Bock, P1
Aalto, M; Grönroos, PE; Irjala, KM; Kantola, IM; Matinlauri, IH; Vesalainen, RK1
Bohlender, J; Dietz, R; Haass, M; Höhnel, K; Luft, FC; Scheuermann, M; Thibault, G; Willenbrock, R1
Jamerson, KA1
Deutsch, P; Ianosi-Irimie, M1
Cooper, ME; Gilbert, RE; Huang, XR; Johnson, RJ; Lai, KN; Lan, HY; Wu, LL; Yang, N; Yu, XQ1
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP1
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL1
Johnson, RJ; Lombardi, DM; Saavedra, JM; Schwartz, SM; Vio, CP; Viswanathan, M1
Kurtz, A; Müller, M; Todorov, V1
Schuitheiss, HP; Tschöpe, C; Walther, T1
Adam, A; Gagnon, C; Gosselin, H; Kapuku, G; Lambert, C; Meloche, S; Pelletier, S; Rouleau, JL1
Ajani, U; Arnold, M; Glynn, R; Greaves, S; Hall, C; Harel, F; Hennekens, C; Pfeffer, M; Rouleau, JL; Sirois, P; Solomon, S; White, M1
Ditiatkov, AE; Radzevich, AE; Tikhonov, VA1
Ehmke, H; Just, A; Kirchheim, HR; Wittmann, U1
Emanueli, C; Gaspa, L; Maddeddu, P; Madeddu, P; Pinna, A; Salis, MB; Stacca, T1
Abbas, A; Brown, NJ; Byrne, D; Schoenhard, JA; Vaughan, DE1
Agabiti-Rosei, E; Bova, S; Neri, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP; Sacchetto, A1
Agabiti-Rosei, E; Bova, S; Cavallin, M; Mazzocchi, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP1
Hankey, GJ1
Bottoms, SE; Chambers, RC; Gohlke, P; Howell, DC; Laurent, GJ; Marshall, RP; McAnulty, RJ; Unger, T1
Unger, T1
Avila-Casado, Mdel C; Bautista, R; Escalante, B; Manning, R; Martinez, F; Medina, A; Soto, V1
Matos, L1
Critchley, J; Critchley, L; Ding, B; Fok, B; James, A; Thomas, GN; Tomlinson, B; Wang, D1
Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E1
Bandinelli, M; Boddi, M; Cecioni, I; Chiavarelli, M; Coppo, M; Lisi, GF; Modesti, PA; Neri Serneri, GG; Papa, ML; Toscano, T1
Unger, T; Zimmermann, M1
Iwasaka, T; Okigaki, M1
Luft, FC1
Avila-Casado, MC; Bautista, R; Coronel, I; Escalante, B; Romo, E; Soto, V; Vázquez, E; Villalón, CM1
Daniel, WG; Eskafi, S; Gabler, C; Garlichs, CD; Illmer, T; Lorenz, HM; Roerick, O; Schmeisser, A; Soehnlein, O; Strasser, R1
Bradbury, AW; Hobbs, SD; Thomas, ME1
Dendorfer, A; Dominiak, P; Raasch, W1
Ahn, YB; Cha, BY; Hong, OK; Jeong, IK; Kim, JW; Kim, MJ; Ko, SH; Son, HY; Song, KH; Yoon, KH1
Dendorfer, A; Dodt, C; Dominiak, P; Jöhren, O; Pahlke, F; Raasch, W; Voges, I; Wittmershaus, C1
Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM1
Cai, W; Chen, JZ; Ruan, LM; Wang, YN1
Blaak, EE; Goossens, GH; Saris, WH; Schiffers, PM; van Baak, MA1
Ambühl, PM; Bachmann, MF; Fulurija, A; Jennings, GT; Maurer, P; Müller, P; Nief, V; Nussberger, J; Pfister, T; Rettenbacher, M; Roubicek, K; Sabat, R; Schellekens, C; Sladko, K; Tissot, AC; Volk, HD; Wagner, F1
Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A1
Adrahtas, A; Cantwell, DM; Kompa, AR; Krum, H; Lewis, DA; See, F; Wang, BH1
Schindler, C1
Araghi, A; Beierwaltes, WH; Doci, TM; Mattingly, R; Yingst, DR1
Angeli, F; Garofoli, M; Gentile, G; Martire, P; Mazzotta, G; Reboldi, G; Verdecchia, P1
Bieri, M; Farkas, A; Ligeti, N; Marti, HP; Meier, B; Mohacsi, P; Oroszlán, M1
Chung, IM; Kim, CK; Kim, YM; Shin, MK; Suh, SH; Yoo, MH1
Mitsuyama, S1
Arfa, O; Czech, T; Ebrahimian, T; Endtmann, C; Fritz, M; Laufs, U; Nickenig, G; Petoumenos, V; Wassmann, K; Wassmann, S; Werner, N1
Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM1
Ayuzawa, N; Fujita, T; Ishizawa, K; Kawarazaki, W; Nagase, M; Takeuchi, M; Ueda, K; Yoshida, S1
D'Angelo, A; Derosa, G; Fogari, R; Gualtierotti, R; Lazzari, P; Mugellini, A; Zoppi, A1
Butori, C; Esnault, VL; Favre, GA; Hofman, P; Lebrun, P; Lopez, P; Van Obberghen, E1
Bessaguet, F; Danigo, A; Demiot, C; Desmoulière, A; Magy, L; Sturtz, F1
Aluko, EO; Fasanmade, AA; Nna, VU1
Funder, JW1
Abouelkheir, M1
Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D1

Reviews

9 review(s) available for angiotensin ii and ramipril

ArticleYear
In vivo concentrations of kinins and angiotensins.
    Hormone and metabolic research. Supplement series, 1990, Volume: 22

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Humans; Hypertension; Kinins; Radioimmunoassay; Ramipril

1990
The present molecules of converting enzyme inhibitors.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System

1985
Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Black People; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diet, Sodium-Restricted; Diuretics; Ethnicity; Humans; Hypertension; Ramipril; Renin; Risk Factors; United States

2000
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?
    Stroke, 2003, Volume: 34, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan

2003
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.
    The American journal of cardiology, 2003, May-22, Volume: 91, Issue:10A

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ramipril; Renin-Angiotensin System; Telmisartan

2003
[New possibilities in clinical use of angiotensin II receptor inhibitors].
    Orvosi hetilap, 2003, Dec-07, Volume: 144, Issue:49

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Ramipril; Renin-Angiotensin System; Survival Analysis; Telmisartan; Treatment Outcome

2003
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1

2004
Manipulation of the renin angiotensin system in peripheral arterial disease.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2004, Volume: 28, Issue:6

    Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Humans; Peripheral Vascular Diseases; Ramipril; Renal Artery Obstruction; Renin-Angiotensin System

2004
Aliskiren versus ramipril in hypertension.
    Therapeutic advances in cardiovascular disease, 2010, Volume: 4, Issue:3

    Topics: Aging; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Fumarates; Half-Life; Humans; Hypertension; Ramipril; Renin-Angiotensin System

2010

Trials

20 trial(s) available for angiotensin ii and ramipril

ArticleYear
Influence of ramipril on plasma atrial natriuretic peptide, antidiuretic hormone, angiotensin II and aldosterone in patients with chronic congestive heart failure.
    Clinical physiology and biochemistry, 1992, Volume: 9, Issue:3

    Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Radioimmunoassay; Ramipril; Sodium; Vasopressins

1992
Is natriuresis on felodipine due to reversal of the renal effects of angiotensin II?
    Kidney international. Supplement, 1992, Volume: 36

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Double-Blind Method; Felodipine; Humans; Kidney; Male; Natriuresis; Ramipril

1992
Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    British journal of clinical pharmacology, 1989, Volume: 28, Issue:6

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Dopamine; Drug Interactions; Electrolytes; Furosemide; Hemodynamics; Humans; Inulin; Kallikreins; Kidney; Male; p-Aminohippuric Acid; Prostaglandins E; Ramipril; Renal Circulation; Renin

1989
First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
    The American journal of cardiology, 1988, Aug-01, Volume: 62, Issue:4

    Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Ramipril; Time Factors

1988
Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
    Journal of hypertension, 1986, Volume: 4, Issue:1

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Drug Interactions; Humans; Male; Norepinephrine; Ramipril; Time Factors

1986
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
    British heart journal, 1994, Volume: 72, Issue:5

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Prognosis; Ramipril; Time Factors

1994
Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
    European heart journal, 1994, Volume: 15, Issue:2

    Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Hormones; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Ramipril

1994
Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Fundamental & clinical pharmacology, 1996, Volume: 10, Issue:5

    Topics: Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Potassium; Ramipril; Renin; Renin-Angiotensin System

1996
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow

1996
A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two yea
    Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:8

    Topics: Adolescent; Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Endothelins; Felodipine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Placebos; Prospective Studies; Ramipril

1997
Response of serum total renin to ramipril and metoprolol in hypertensive patients.
    Scandinavian journal of clinical and laboratory investigation, 1998, Volume: 58, Issue:8

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin

1998
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.
    American heart journal, 2001, Volume: 142, Issue:6

    Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Catecholamines; Dopamine; Double-Blind Method; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Ramipril; Stroke Volume; Ventricular Remodeling

2001
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Circulation, 2002, Jan-22, Volume: 105, Issue:3

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Ramipril; Renin; Single-Blind Method; Tissue Plasminogen Activator

2002
Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
    Circulation research, 2004, Jun-25, Volume: 94, Issue:12

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chymases; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Cytokines; Female; Gene Expression Profiling; Humans; Male; Microcirculation; Middle Aged; Mitral Valve Stenosis; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Preoperative Care; Ramipril; Renin-Angiotensin System; RNA, Messenger; Serine Endopeptidases; Tetrazoles; Valine; Valsartan; Vasculitis

2004
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome

2004
Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects.
    Diabetologia, 2006, Volume: 49, Issue:12

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Double-Blind Method; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Placebos; Ramipril

2006
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
    Journal of hypertension, 2007, Volume: 25, Issue:1

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibody Specificity; Antihypertensive Agents; Autoantibodies; Blood Pressure; Disease Models, Animal; Double-Blind Method; Drug Evaluation, Preclinical; Humans; Hypertension; Male; Mice; Mice, Inbred BALB C; Middle Aged; Patient Compliance; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Time Factors; Vaccines; Virion

2007
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
    European journal of heart failure, 2007, Volume: 9, Issue:11

    Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fumarates; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Renin; Statistics, Nonparametric; Treatment Outcome

2007
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:3

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Apoptosis; Benzimidazoles; Benzoates; Blood Vessels; Bone Marrow Transplantation; Cell Count; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Ramipril; Receptor, Angiotensin, Type 1; Regeneration; Stem Cells; Telmisartan; Vasoconstrictor Agents

2011
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:18

    Topics: Adult; Aged; Albumins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazolidines; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Ramipril; Treatment Outcome

2013

Other Studies

97 other study(ies) available for angiotensin ii and ramipril

ArticleYear
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
    Biochemical and biophysical research communications, 1992, Jan-15, Volume: 182, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bridged Bicyclo Compounds; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Imidazoles; Kinins; Losartan; Male; Muscle, Smooth, Vascular; Oligopeptides; Ramipril; Rats; Rats, Inbred Strains; Tetrazoles

1992
[Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
    Klinische Wochenschrift, 1991, Volume: 69 Suppl 24

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Bridged Bicyclo Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Techniques; Dose-Response Relationship, Drug; Gallic Acid; Muscle, Smooth, Vascular; Pyrroles; Ramipril; Rats; Verapamil

1991
Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man.
    Journal of hypertension, 1991, Volume: 9, Issue:11

    Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Female; Humans; Kidney Cortex; Male; Middle Aged; Myocardium; Peptidyl-Dipeptidase A; Ramipril; Reference Values; Renin; Surgical Procedures, Operative; Time Factors

1991
Effects of ramipril on arterial hemodynamics.
    Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Blood Volume; Brachial Artery; Bridged Bicyclo Compounds; Carotid Arteries; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Vascular Resistance

1991
Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
    Basic research in cardiology, 1991, Volume: 86 Suppl 3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Catecholamines; Corticosterone; Desipramine; Epinephrine; Heart; Myocardium; Norepinephrine; Ramipril; Rats; Rats, Inbred SHR; Tubocurarine; Vagotomy

1991
Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Bridged Bicyclo Compounds; Cardiomegaly; Constriction; Hypertension; Imidazoles; Losartan; Male; Ramipril; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles

1991
Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats.
    European journal of pharmacology, 1990, Jun-08, Volume: 181, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Volume; Bridged Bicyclo Compounds; Erythrocyte Count; Erythropoiesis; Erythropoietin; Hematocrit; Male; Ramipril; Rats; Rats, Inbred WKY; Renin; Reticulocytes

1990
Converting enzyme inhibition in kinin-deficient brown Norway rats.
    Hypertension (Dallas, Tex. : 1979), 1990, Volume: 16, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Kinins; Male; Ramipril; Rats; Rats, Inbred BN; Species Specificity

1990
Roles of peripheral and central angiotensin-converting enzyme (ACE) in hypovolemic thirst induced by compound 48/80 in rats.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Bridged Bicyclo Compounds; Drinking; Injections, Intraventricular; Male; p-Methoxy-N-methylphenethylamine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred Strains; Thirst

1990
Vascular angiotensin conversion in humans.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 10

    Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Forearm; Humans; Hypertension; Kinetics; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Reference Values; Regional Blood Flow; Renin

1986
Converting enzyme inhibitors and brain angiotensin.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 10

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Enalaprilat; Kinetics; Male; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY

1986
Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 3

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Creatinine; Female; Heart Rate; Humans; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Time Factors

1989
Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 3

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Humans; Hypertension; Kallikreins; Kinins; Middle Aged; Proline; Radioimmunoassay; Ramipril; Renin; Sodium

1989
Modulation of natriuresis by sympathetic nerves and angiotensin II in conscious dogs.
    The American journal of physiology, 1989, Volume: 256, Issue:3 Pt 2

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Carotid Arteries; Dogs; Glomerular Filtration Rate; Kidney; Natriuresis; Ramipril; Reference Values; Reflex; Renal Artery; Renin; Sympathetic Nervous System

1989
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
    Clinical and experimental hypertension. Part A, Theory and practice, 1989, Volume: 11, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Cardiomegaly; Dihydralazine; Hypertension; Male; Nifedipine; Ramipril; Rats; Rats, Inbred Strains

1989
Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Advances in experimental medicine and biology, 1989, Volume: 247A

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Diuresis; Heart Rate; Humans; Hypertension; Kallikreins; Kinins; Ramipril; Renin-Angiotensin System

1989
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
    Cardiovascular drugs and therapy, 1989, Volume: 3, Issue:6

    Topics: Action Potentials; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Bradykinin; Bridged Bicyclo Compounds; Digoxin; Female; Guinea Pigs; Heart; In Vitro Techniques; Lidocaine; Male; Rabbits; Ramipril; Rats; Rats, Inbred Strains

1989
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
    European journal of pharmacology, 1989, Jul-18, Volume: 166, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Saralasin

1989
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
    Behavioral neuroscience, 1988, Volume: 102, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drinking; Enalapril; Ramipril; Rats; Rats, Inbred Strains; Renin; Sodium Chloride

1988
[Interaction of chronic inhibition of the angiotensin-converting enzyme and the sympathetic system: effect of added sodium chloride load].
    Zeitschrift fur Kardiologie, 1988, Volume: 77 Suppl 3

    Topics: Adrenal Glands; Angiotensin II; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Epinephrine; Hypertension; Male; Myocardium; Ramipril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium, Dietary; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Water-Electrolyte Balance

1988
Intrarenal generation of angiotensin II evaluated by an electrophysiological technique.
    The American journal of physiology, 1987, Volume: 252, Issue:4 Pt 2

    Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Bridged Bicyclo Compounds; Captopril; Female; Hydronephrosis; Juxtaglomerular Apparatus; Kidney; Membrane Potentials; Mice; Ramipril; Renin

1987
Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
    The American journal of cardiology, 1987, Apr-24, Volume: 59, Issue:10

    Topics: Adult; Aged; Angiotensin I; Angiotensin II; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Forearm; Humans; Middle Aged; Ramipril; Regional Blood Flow; Renin

1987
Tissue renin-angiotensin systems: focus on the heart.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1987, Volume: 5, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Heart; Macaca mulatta; Myocardium; Rabbits; Ramipril; Rats; Renin-Angiotensin System

1987
[Effects of conversion enzyme inhibitors on the synthesis of angiotensin II by the isolated rat kidney].
    Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Kidney; Male; Ramipril; Rats; Rats, Inbred Strains

1987
Measurement and characterization of angiotensin peptides in plasma.
    Clinical chemistry, 1988, Volume: 34, Issue:6

    Topics: Adult; Angiotensin I; Angiotensin II; Animals; Blood Specimen Collection; Bridged Bicyclo Compounds; Chromatography, High Pressure Liquid; Female; Humans; Iodine Radioisotopes; Male; Nephrectomy; Radioimmunoassay; Ramipril; Rats; Reference Values

1988
Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
    Journal of clinical hypertension, 1986, Volume: 2, Issue:3

    Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Humans; Male; Ramipril; Renin

1986
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1986, Volume: 4, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System

1986
Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
    The American journal of cardiology, 1987, Apr-24, Volume: 59, Issue:10

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Female; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Male; Middle Aged; Potassium; Ramipril; Renal Artery Obstruction; Renin-Angiotensin System

1987
Heart and vascular wall as targets for tissue converting enzyme inhibition.
    Clinical and experimental hypertension. Part A, Theory and practice, 1987, Volume: 9, Issue:2-3

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Vessels; Bradykinin; Bridged Bicyclo Compounds; Endothelium; Guinea Pigs; Heart; In Vitro Techniques; Muscle, Smooth, Vascular; Myocardium; Ramipril; Rats

1987
Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1986, Volume: 4, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain; Hypertension; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spinal Cord

1986
Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices.
    Clinical and experimental hypertension. Part A, Theory and practice, 1984, Volume: 6, Issue:10-11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Bridged Bicyclo Compounds; Captopril; Clonidine; Dipeptides; Enalaprilat; In Vitro Techniques; Norepinephrine; Ramipril; Rats

1984
Attenuation of cyclosporine A-induced vascular toxicity by ramipril.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:1

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Cyclosporine; Endothelium, Vascular; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Ramipril; Rats; Rats, Wistar

1994
Effects of ramipril on contractile oscillations in arteries from genetically hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1994, Volume: 16, Issue:6

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Age Factors; Angiotensin II; Animals; Aorta; Blood Pressure; Carotid Arteries; Hypertension; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oscillometry; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction

1994
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    The Annals of thoracic surgery, 1995, Volume: 60, Issue:3

    Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles

1995
Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Aug-15, Volume: 92, Issue:17

    Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Enzyme Precursors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Imidazoles; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles

1995
Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Acta physiologica Scandinavica, 1994, Volume: 152, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diclofenac; Dogs; Electric Stimulation; Female; Norepinephrine; Perfusion; Prostaglandins; Ramipril; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction

1994
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog.
    Circulation, 1994, Volume: 90, Issue:6

    Topics: Adrenergic alpha-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Hemodynamics; Magnetic Resonance Imaging; Myocardium; Phenylephrine; Ramipril; Receptors, Angiotensin; Renin; Stress, Mechanical; Ventricular Function

1994
Interrelation between renin mRNA levels, renin secretion, and blood pressure in two-kidney, one clip rats.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Hypertension, Renovascular; Male; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger

1994
Converting enzyme inhibition and renal tissue angiotensin II in the rat.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:4

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enalapril; Kidney; Male; Radioimmunoassay; Ramipril; Rats; Rats, Sprague-Dawley

1994
Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:4

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Corticosterone; Fasting; Hydroxysteroid Dehydrogenases; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Tritium

1994
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:5

    Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole

1993
Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:5

    Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Atria; Imidazoles; In Vitro Techniques; Kinetics; Losartan; Male; Myocardium; Norepinephrine; Ramipril; Receptors, Angiotensin; Tetrazoles

1993
Dose-response differences in the ability of ramipril to improve retention in diabetic mice.
    European journal of pharmacology, 1993, Aug-24, Volume: 240, Issue:2-3

    Topics: Angiotensin I; Angiotensin II; Animals; Avoidance Learning; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Ramipril; Retention, Psychology

1993
Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; Cell Division; Cells, Cultured; Collagen; DNA; Drug Synergism; Fibronectins; Gelatin; Imidazoles; Losartan; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Ramipril; Rats; Recombinant Proteins; Stress, Mechanical; Tetrazoles; Thymidine

1993
Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet.
    Atherosclerosis, 1993, Volume: 100, Issue:2

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Endothelium, Vascular; Hyperlipidemias; In Vitro Techniques; Male; Nitroglycerin; Phenylephrine; Rabbits; Ramipril; Vasodilation

1993
Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Chromatography, High Pressure Liquid; Male; Nephrectomy; Peptides; Peptidyl-Dipeptidase A; Radioimmunoassay; Ramipril; Rats; Rats, Sprague-Dawley; Reference Values; Renin

1993
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles

1993
Long-term effects of brief antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats.
    Cardiovascular drugs and therapy, 1995, Volume: 9, Issue:3

    Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Hydralazine; Hydrochlorothiazide; Hypertension; Linear Models; Muscle Contraction; Muscle, Smooth, Vascular; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance

1995
Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents

1996
Regulation of ANG II receptor in hypertension: role of ANG II.
    The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Gene Expression; Hypertension; Imidazoles; Losartan; Male; Nephrectomy; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta

1996
The urinary bladder angiotensin system: response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 28, Issue:4

    Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Enalaprilat; Male; Ramipril; Rats; Rats, Sprague-Dawley; Urinary Bladder

1996
Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade.
    Immunopharmacology, 1996, Volume: 33, Issue:1-3

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles

1996
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Journal of hypertension, 1995, Volume: 13, Issue:12 Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation

1995
Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites.
    Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arachidonic Acid; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Hypercholesterolemia; Iliac Artery; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Masoprocol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Rabbits; Ramipril; Vasoconstrictor Agents

1997
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Diabetes, 1997, Volume: 46, Issue:10

    Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan

1997
[Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Archives des maladies du coeur et des vaisseaux, 1997, Volume: 90, Issue:8

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renal; In Vitro Techniques; Kidney; Male; Ramipril; Rats; Rats, Inbred SHR; Renin; Time Factors

1997
The arterial length-densities under preventive angiotensin-converting-enzyme inhibiting treatment in the myocardium of spontaneously hypertensive rats.
    Basic research in cardiology, 1998, Volume: 93, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillaries; Coronary Vessels; Dose-Response Relationship, Drug; Hypertension; Myocardium; Neovascularization, Pathologic; Organ Size; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Vasoconstrictor Agents

1998
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Heart Failure; Male; Myocardium; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Statistics, Nonparametric; Tetrazoles; Valine; Valsartan

1999
Renin-angiotensin system inhibitors as antihypertrophic agents.
    Die Pharmazie, 2000, Volume: 55, Issue:8

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System

2000
Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
    Kidney international, 2000, Volume: 58, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Disease Models, Animal; Gene Expression; In Situ Hybridization; Kidney; Macrophages; Male; Nephrectomy; Nephritis, Interstitial; Osteopontin; Ramipril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Valine; Valsartan

2000
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling

2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
    Diabetologia, 2000, Volume: 43, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent.
    Nephron, 2001, Volume: 87, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carotid Artery Injuries; Catheterization; Kidney Diseases; Losartan; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents

2001
Differential regulation of cathepsin B and prorenin gene expression in renal juxtaglomerular cells.
    Kidney & blood pressure research, 2001, Volume: 24, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cathepsin B; Cell Line; Diet, Sodium-Restricted; Enzyme Induction; Enzyme Precursors; Gene Expression Regulation; Homeostasis; Juxtaglomerular Apparatus; Male; Mice; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetradecanoylphorbol Acetate; Water-Electrolyte Balance

2001
Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus.
    Cardiovascular research, 2001, Aug-15, Volume: 51, Issue:3

    Topics: Angiotensin II; Animals; Blotting, Northern; Diabetes Mellitus, Experimental; Gene Expression Regulation; Kidney Cortex; Losartan; Male; Natriuretic Peptide, C-Type; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger

2001
Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway.
    Circulation, 2001, Aug-21, Volume: 104, Issue:8

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; GTP-Binding Proteins; Hemodynamics; In Vitro Techniques; Kinins; Losartan; Male; Myocardial Contraction; Myocardium; Organ Size; Papillary Muscles; Protein Subunits; Pulmonary Artery; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Ventricular Dysfunction, Right

2001
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
    Problemy tuberkuleza, 2001, Issue:8

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary

2001
Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog.
    The Journal of physiology, 2002, Jan-01, Volume: 538, Issue:Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dogs; Homeostasis; Ramipril; Renal Circulation; Vascular Resistance

2002
Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Extremities; Femoral Artery; Gene Expression; Ischemia; Losartan; Male; Mice; Neovascularization, Physiologic; Peptidyl-Dipeptidase A; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction

2002
Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension.
    American journal of hypertension, 2002, Volume: 15, Issue:2 Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Aorta; Benzazepines; Blood Pressure; Body Weight; Cardiovascular Diseases; Hypertension; In Vitro Techniques; Male; Neprilysin; Organ Size; Pyridines; Ramipril; Rats; Vasoconstriction

2002
Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
    Journal of hypertension, 2002, Volume: 20, Issue:7

    Topics: Adrenomedullin; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Heart; Hypertension; Male; Models, Cardiovascular; Neprilysin; Organ Size; Peptides; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Bradykinin; Severity of Illness Index; Systole; Treatment Outcome; Vasoconstrictor Agents

2002
Angiotensin II and the fibroproliferative response to acute lung injury.
    American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:1

    Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Humans; Losartan; Lung; Peptidyl-Dipeptidase A; Procollagen; Pulmonary Fibrosis; Ramipril; Renin-Angiotensin System; Transforming Growth Factor beta

2004
Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension.
    American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cell Membrane; Gene Expression; Glucose; Hypertension, Renal; Immunoblotting; Kidney Cortex; Losartan; Male; Monosaccharide Transport Proteins; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium; Sodium-Glucose Transporter 2

2004
The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.
    European journal of pharmacology, 2004, Apr-05, Volume: 489, Issue:1-2

    Topics: Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Denervation; Dogs; Electric Stimulation; Homeostasis; Male; Ramipril; Stimulation, Chemical; Tetrazoles

2004
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Circulation, 2004, May-11, Volume: 109, Issue:18

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides

2004
Cardiac angiotensin is upregulated in the hearts of unstable angina patients.
    Circulation research, 2004, Jun-25, Volume: 94, Issue:12

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Electrocardiography; Humans; Male; Middle Aged; Models, Cardiovascular; Myocardium; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2004
Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation.
    American journal of physiology. Renal physiology, 2005, Volume: 288, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Diuresis; Gene Expression Regulation; Imidazoles; Kidney; Ligation; Losartan; Male; Nephrectomy; Proteinuria; Pyridines; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Artery; RNA, Messenger

2005
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Biochemical and biophysical research communications, 2004, Dec-10, Volume: 325, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Chemokine CCL2; Chemokines; Down-Regulation; Drug Interactions; Endothelium, Vascular; Humans; Imidazoles; Interleukin-8; Losartan; Monocytes; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Simvastatin; Umbilical Veins

2004
Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Journal of hypertension, 2005, Volume: 23, Issue:8

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Indans; Male; Neprilysin; Norepinephrine; Peptidyl-Dipeptidase A; Propionates; Protease Inhibitors; Pyridines; Ramipril; Rats; Rats, Inbred SHR; Thiazepines

2005
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.
    Journal of cellular biochemistry, 2006, May-15, Volume: 98, Issue:2

    Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Pancreatitis; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta

2006
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.
    Endocrinology, 2006, Volume: 147, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Corticosterone; Gene Expression Regulation; Hypothalamus; Male; Mibefradil; Pituitary-Adrenal System; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles

2006
Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Experimental eye research, 2006, Volume: 83, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases

2006
Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.
    Journal of Zhejiang University. Science. B, 2006, Volume: 7, Issue:8

    Topics: Angiotensin II; Animals; Arteriosclerosis; Body Weight; Cholesterol; Connexin 43; Losartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rabbits; Ramipril; RNA, Messenger

2006
Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:3

    Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cells, Cultured; Collagen; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Imidazoles; Myocardial Infarction; Myocytes, Cardiac; Neoplasm Proteins; Organ Size; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling

2008
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan

2008
Decreased renal perfusion rapidly increases plasma membrane Na-K-ATPase in rat cortex by an angiotensin II-dependent mechanism.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:5

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biotin; Blood Pressure; Cell Membrane; In Vitro Techniques; Kidney Cortex; Male; Microsomes; Ramipril; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Renin; Sodium-Potassium-Exchanging ATPase

2009
Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway.
    Transplant immunology, 2010, Volume: 23, Issue:3

    Topics: Albumins; Angiotensin II; Cell Line; Down-Regulation; Drug Therapy, Combination; Endocytosis; Epithelial Cells; Everolimus; Humans; Immunosuppressive Agents; Kidney Tubules, Proximal; Losartan; Low Density Lipoprotein Receptor-Related Protein-2; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction; Sirolimus

2010
Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway.
    Atherosclerosis, 2010, Volume: 213, Issue:1

    Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arteries; Atherosclerosis; Immobilization; Losartan; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Ramipril; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin

2010
[Prevention of hypertension by drugs and immunization against angiotensin II].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011, Feb-10, Volume: 100, Issue:2

    Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Vaccines

2011
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
    British journal of pharmacology, 2012, Volume: 165, Issue:8

    Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain

2012
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
    Clinical and experimental nephrology, 2014, Volume: 18, Issue:4

    Topics: Albuminuria; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progression; Down-Regulation; Fumarates; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Ramipril; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors

2014
Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2014, Volume: 15, Issue:4

    Topics: Angiotensin II; Animals; Area Under Curve; Creatinine; Drinking; Energy Metabolism; Gene Expression Regulation; Glucose Tolerance Test; Homeostasis; Humans; Hypertension; Insulin; Insulin Secretion; Intra-Abdominal Fat; Kidney Function Tests; Kidney Tubules, Proximal; Mice, Inbred C57BL; Mice, Transgenic; Muscles; Organ Size; Phenotype; Ramipril; Renin-Angiotensin System

2014
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
    Neuropharmacology, 2017, Volume: 126

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Diterpenes; Ganglia, Spinal; Imidazoles; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pyridines; Ramipril; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Small Fiber Neuropathy; Substance P; Tetrazoles

2017
Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats.
    Archives of physiology and biochemistry, 2022, Volume: 128, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Hypertension; Hypoglycemic Agents; Insulins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Prostaglandins I; Ramipril; Rats; Rats, Wistar

2022
Primary Aldosteronism: The Next Decade.
    Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:2

    Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Ramipril; Renin

2020
Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities.
    Current molecular pharmacology, 2022, Volume: 15, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Lisinopril; Pyrimidines; Ramipril; Rats; Rats, Sprague-Dawley

2022
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
    Biochemical pharmacology, 2023, Volume: 215

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb; Heart Failure; Humans; Mice; Ramipril; Reactive Oxygen Species; Spironolactone

2023